Biologic treatment for bowel narrowing in Crohn’s disease
Part of Digestive system, Immune system & allergy clinical trials.
This trial studies biologic medicines to treat Crohn’s disease that causes bowel narrowing (“strictures”) without needing immediate surgery. It may help reduce symptoms and complications by targeting the immune-driven inflammation behind the narrowing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Crohn’s disease with bowel narrowing (strictures).
- Your doctor does not think you need surgery right now for this problem.
- Your Crohn’s may include small “penetrating” areas, but they must be without symptoms right now.
- You can give written consent to join the study.
- You are not having penetrating Crohn’s symptoms (for example, draining areas, abscess-type symptoms, or pain from an active tract).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to treat narrowed areas (strictures) in the gut caused by Crohn's disease: endoscopic strictureplasty versus balloon dilation. It aims to see which method works better for people whose strictures are manageable with a scope.
This study compares two timing choices for surgery in people with Crohn’s disease who have bowel narrowing (strictures) causing blockage symptoms. The goal is to see whether operating earlier leads to better control of symptoms and inflammation when other treatments haven’t worked.
This study compares two medicines, Guselkumab and Ustekinumab, for people with Crohn's disease that causes narrowing (strictures) in the bowel. It aims to find which works better to improve symptoms and avoid the need for more procedures.
This trial tests a new approach that combines two procedures (stricturotomy and balloon dilation) against stricturotomy alone to treat short narrowed areas (strictures) caused by Crohn's disease. The goal is to see which method works better for keeping the bowel open longer.
This study looks at inflammation just before a narrowed section of the bowel in people with Crohn’s disease, using planned endoscopic balloon dilation. It may help doctors better understand what drives narrowing and inflammation so treatment can be timed and chosen more effectively.
This study compares a medical treatment approach versus surgery for people with Crohn’s disease that causes narrowing (strictures) in the small intestine and blocking symptoms. It aims to see which approach works better in easing symptoms and preventing problems from the narrowing.
Hear when a new The Efficacy of Biologics for Stricturing Crohn's Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.